Nardi G, Valentinis U, Proietti A, De Monte A, Di Silvestre A, Muzzi R, Peressutti R, Troncon M G, Giordano F
2nd Department of Anaesthesia, Hospital of Udine, Italy.
Intensive Care Med. 1993;19(5):273-8. doi: 10.1007/BF01690547.
to evaluate the effect of the prolonged systematic use of topical SDD (tobramycin 80 mg, polymyxin E 100 mg, amphotericin B 500 mg) on ICU ecology as expressed by changes in tracheal colonization and bacterial resistances.
Prospective microbiological survey.
Polyvalent ICU of a 2000 beds general hospital.
Data concerning bacterial strains isolated from the tracheo-bronchial aspirates of all the patients admitted to a polyvalent ICU over 3 consecutive periods of 12 months ('88, '89, '90) were prospectively entered in a database and subsequently analyzed. During a 3-year period 502 patients required artificial ventilation for more than 72 h and 332 of them ('89 and '90) were treated with SDD. All samples collected within 72 h from ICU admission were excluded as well as duplicate samples from the same patients.
All the patients admitted to the ICU in '89 and '90 and submitted to artificial ventilation for at least 24 h were routinely treated with topical SDD without i.v. antibiotic prophylaxis; in '88 SDD was not employed.
Criteria for collecting sputum samples and microbiological procedures remained unchanged throughout the study-time. Positive sputum were significantly less in '89 (80.8% versus 92.3% p < 0.001) and this was due to a very sharp decrease in the isolation of Gram-negative strains from 43-28% (-64% p < 0.0001) involving both: Enterobacteriaceae (-45%) and Pseudomonaceae (-77%). In 1990; however, a new increase in Gram negative was observed, although the overall amount of Gram-negative was still 49% lower in '90 if compared to '88 (p < 0.0001). A dramatic increase in Pseudomonas isolation was the only factor responsible for the "rebound" observed. An increasing percentage of Pseudomonas developed a resistance towards tobramycin and only 45% of Pseudomonas strains turned out to be sensible to tobramycin in '90 against 79% in '88. A similar trend was registered for all aminoglycosides with the exception of amikacin. Gram-positive colonizations tended to increase (+63%) (p < 0.0001) and this was mainly due to Coagulase negative Staphylococci (+290% p < 0.0001) and S. pneumoniae, whereas S. aureus isolations decreased (-18%) but not significantly.
Our data suggest that the prolonged use of SDD is associated with dramatic changes in ICU ecology: the incidence of Gram negative colonization is significantly diminished by SDD whereas Gram positive tend to increase. Pseudomonas developed an increasing resistance towards tobramycin one of the components of the SDD formula we used.
通过气管定植和细菌耐药性的变化来评估长期系统性使用局部SDD(妥布霉素80毫克、多粘菌素E 100毫克、两性霉素B 500毫克)对重症监护病房(ICU)生态的影响。
前瞻性微生物学调查。
一家拥有2000张床位的综合医院的多科室ICU。
在连续3个12个月期间(1988年、1989年、1990年)入住多科室ICU的所有患者的气管支气管吸出物中分离出的细菌菌株数据被前瞻性地录入数据库并随后进行分析。在3年期间,502名患者需要人工通气超过72小时,其中332名(1989年和1990年)接受了SDD治疗。从ICU入院后72小时内收集的所有样本以及同一患者的重复样本均被排除。
1989年和1990年入住ICU且接受至少24小时人工通气的所有患者常规接受局部SDD治疗,不进行静脉抗生素预防;1988年未使用SDD。
在整个研究期间,痰标本采集标准和微生物学程序保持不变。1989年痰标本阳性率显著降低(80.8%对92.3%,p<0.001),这是由于革兰氏阴性菌的分离率急剧下降,从43%降至28%(-64%,p<0.0001),涉及肠杆菌科(-45%)和假单胞菌科(-77%)。然而,在1990年,革兰氏阴性菌又出现了新的增加,尽管与1988年相比,1990年革兰氏阴性菌的总量仍低49%(p<0.0001)。假单胞菌分离率的急剧增加是观察到“反弹”的唯一原因。对妥布霉素耐药的假单胞菌百分比不断增加,1990年只有45%的假单胞菌菌株对妥布霉素敏感,而1988年为79%。除阿米卡星外,所有氨基糖苷类药物都呈现类似趋势。革兰氏阳性菌定植倾向于增加(+63%)(p<0.0001),这主要是由于凝固酶阴性葡萄球菌(+290%,p<0.0001)和肺炎链球菌,而金黄色葡萄球菌的分离率下降(-18%)但不显著。
我们的数据表明,长期使用SDD与ICU生态的显著变化有关:SDD可显著降低革兰氏阴性菌定植的发生率,而革兰氏阳性菌则倾向于增加。我们使用的SDD配方中的成分之一妥布霉素,使假单胞菌对其耐药性不断增加。